| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 121 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 116 |
| 2 | TACROLIMUS OINTMENT 0.1% | 116 |
| 3 | PREDNISONE | 107 |
| 4 | MYCOPHENOLATE MOFETIL | 105 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 105 |
| 6 | METHYLPREDNISOLONE | 84 |
| 7 | METHOTREXATE SODIUM | 82 |
| 8 | METHOTREXATE | 76 |
| 9 | CYCLOPHOSPHAMIDE | 72 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VANCOMYCIN HYDROCHLORIDE | 24 | 0.0029 |
| 1 | ADO-TRASTUZUMAB EMTANSINE | 16 | 0.0019 |
| 2 | MICAFUNGIN SODIUM | 9 | 0.0014 |
| 3 | BASILIXIMAB | 15 | 0.0013 |
| 4 | DEXAMETHASONE SODIUM PHOSPHATE | 12 | 0.0012 |
| 5 | PEGASPARGASE | 13 | 0.0011 |
| 6 | TACROLIMUS OINTMENT 0.1% | 116 | 0.0009 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 116 | 0.0009 |
| 8 | GOLIMUMAB | 11 | 0.0009 |
| 9 | POSACONAZOLE | 13 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 285 |
| 1 | Alkylating Drug [EPC] | 88 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 84 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 76 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 67 |
| 5 | Kinase Inhibitor [EPC] | 54 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 51 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 48 |
| 8 | Azole Antifungal [EPC] | 40 |
| 9 | Benzodiazepine [EPC] | 40 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 11 | 0.0160 |
| 1 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 2 | 0.0016 |
| 2 | Echinocandin Antifungal [EPC] | 11 | 0.0013 |
| 3 | Antiparasitic [EPC] | 5 | 0.0011 |
| 4 | Endoglycosidase [EPC] | 2 | 0.0011 |
| 5 | Pediculicide [EPC] | 5 | 0.0011 |
| 6 | Tyrosine Kinase 2 Inhibitor [EPC] | 3 | 0.0010 |
| 7 | Asparagine-specific Enzyme [EPC] | 13 | 0.0010 |
| 8 | Surfactant [EPC] | 1 | 0.0009 |
| 9 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |